123 related articles for article (PubMed ID: 13778521)
21. [NEUTRALIZATION OF EXOGENOUS HEPARIN BY PROTAMINE OR POLYBRENE IN SUBEQUIVALENT QUANTITIES AFTER ARTIFICIAL PERFUSION].
PAUSESCU E; MARINESCU A
Z Gesamte Inn Med; 1964 Jul; 19():SUPPL:38-43. PubMed ID: 14231857
[No Abstract] [Full Text] [Related]
22. The neutralization of heparin with polybrene.
HOHF R; PRESTON FW; TRIPPEL O
Q Bull Northwest Univ Med Sch; 1956; 30(2):138-43. PubMed ID: 13359634
[No Abstract] [Full Text] [Related]
23. Changes in blood-coagulation due to perfusion for cardiac surgery.
ROTHNIE NG; NORMAN AG; STEELE M; KINMONTH JB
Br J Surg; 1960 Nov; 48():272-81. PubMed ID: 13743898
[No Abstract] [Full Text] [Related]
24. HEPARIN METABOLISM AS RELATED TO TIME AND TEMPERATURE.
THOMSON NB; EHRLICH F
J Thorac Cardiovasc Surg; 1964 Jul; 48():19-28. PubMed ID: 14155511
[No Abstract] [Full Text] [Related]
25. [Exact determination of the actual blood heparin content at the moment when it is neutralized by polybrene or protamine sulfate].
RABY C; SERVELLE M
Hemostase; 1962 Dec; 2():325-8. PubMed ID: 13972909
[No Abstract] [Full Text] [Related]
26. THE ANTICOAGULANT ACTION OF POLYBRENE.
ZIPURSKY A; WODZICKI AM; RUSSET JI; ISRAELS ED; ISRAELS LG
Can J Physiol Pharmacol; 1965 Mar; 43():289-97. PubMed ID: 14329336
[No Abstract] [Full Text] [Related]
27. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.
EGERTON WS; ROBINSON CL
Lancet; 1961 Sep; 2(7203):635-7. PubMed ID: 13725907
[No Abstract] [Full Text] [Related]
28. Heparin neutralization with polybrene administered intravenously.
WEISS WA; GILMAN JS; CATENACCI AJ; OSTERBERG AE
J Am Med Assoc; 1958 Feb; 166(6):603-7. PubMed ID: 13502035
[No Abstract] [Full Text] [Related]
29. [Comparative study of the effects "in vitro" of polybrene and protamine on normal and heparinized blood].
RABY C; FERNAND-LAURENT J; BERTRAND H
Hemostase; 1962 Dec; 2():315-24. PubMed ID: 13972908
[No Abstract] [Full Text] [Related]
30. Hexadimethrine and protamine as antiheparin agents. An experimental comparison after totalbody perfusion in dogs.
GOLDMAN R; HOHF RP
Arch Surg; 1962 Sep; 85():497-502. PubMed ID: 13899835
[No Abstract] [Full Text] [Related]
31. A study with low and high molecular weights of hexadimethrine bromide-an antiheparin agent.
KIMURA ET; YOUNG PR; BARLOW GH
Proc Soc Exp Biol Med; 1962 Oct; 111():37-41. PubMed ID: 14032756
[No Abstract] [Full Text] [Related]
32. SOME EFFECTS OF CATIONIC POLYMERS ON CELL ATTACHMENT AND GROWTH BEHAVIOR: STUDIES WITH POLYBRENE.
NORDLING S; SAXEN E; PENTTINEN K
Acta Pathol Microbiol Scand; 1965; 63():28-36. PubMed ID: 14276525
[No Abstract] [Full Text] [Related]
33. A comparative study of heparin neutralization and the danger of blood clotting abnormalities with protamine and polybrene.
ANDERSEN MN; MENDELOW M; ALFANO GA
J Thorac Cardiovasc Surg; 1960 May; 39():613-8. PubMed ID: 13793330
[No Abstract] [Full Text] [Related]
34. EXPERIMENTAL HEXADIMETHRINE NECROSIS OF ANTERIOR PITUITARY.
KOVACS K; CARROLL R; TAPP E
Lancet; 1964 Oct; 2(7366):919-21. PubMed ID: 14203927
[No Abstract] [Full Text] [Related]
35. EXPERIMENTAL HEXADIMETHRINE NECROSIS OF ZONA GLOMERULOSA AND INNER LAYERS OF ADRENAL CORTEX.
CARROLL R; KOVACS K; TAPP E
Lancet; 1964 Oct; 2(7366):921-4. PubMed ID: 14203928
[No Abstract] [Full Text] [Related]
36. [Study of the anitheparin activity of polymeric quaternary ammonium salts, analogs of polybrene].
Efimov VS; Guliaeva ZhG; Men'shova GI; Razvodovskiĭ EF; Zezin AB
Farmakol Toksikol; 1974; 37(6):688-92. PubMed ID: 4464096
[No Abstract] [Full Text] [Related]
37. [The neutralization of heparin during extracorporeal circulation. Experimentation with a new anti-heparin product].
BITTARD M; REMIGY E; MARTIN J; BENICHOUX R
Rev Med Nancy; 1960 Jul; 85():606-15. PubMed ID: 13801050
[No Abstract] [Full Text] [Related]
38. Some pharmacologic characteristics of hexadimethrine bromide (polybrene); a new antiheparin agent.
KIMURA ET; YOUNG PR; STEIN RJ; RICHARDS RK
Toxicol Appl Pharmacol; 1959 Mar; 1(2):185-202. PubMed ID: 13635688
[No Abstract] [Full Text] [Related]
39. SOME HAEMATOLOGICAL OBSERVATIONS IN CARDIOPULMONARY BYPASS AT NORMOTHERMIA USING THE MELROSE OXYGENATOR.
CUMMING RA; DAVIES SH; KAMEL K; MACKENZIE GJ; MASSON A; WADE JD
Thorax; 1964 Mar; 19(2):170-5. PubMed ID: 14128574
[No Abstract] [Full Text] [Related]
40. Organ lesions produced by hexadimethrine and their modification by various agents.
SELYE H; CABBIANI G; TUCHWEBER B
Med Exp Int J Exp Med; 1963; 8():74-82. PubMed ID: 13987852
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
